stella
beta
A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects — Stella
Recruiting
Back to Healthy Adult Male trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(4 sites)
Russia
I.M. Sechenov First Moscow State Medical University, Moscow
LLC "X7 Clinical Research", Saint Petersburg
LLC "Research Center Eco-Safety", Saint Petersburg
LLC "X7 Clinical Research", Saint Petersburg
View full record on ClinicalTrials.gov